Assembly Bill 3129 would have given the California Attorney General oversight of all private equity investments or purchases involving a healthcare entity. Gov. Gavin Newsom argued that a similar regulatory framework is already in place. 

A federal judge in California ruled existing evidence of the negative effects of fluoride in drinking water warrants an investigation and potential action from the Environmental Protection Agency. 

Blue Cross and Blue Shield of Louisiana failed to fully reimburse St. Charles Surgical Hospital for 7,800 procedures, despite authorizing them.

The class action lawsuit argues employees cannot escape the fees even after they stop using tobacco, a violation of labor regulations.  

Particle Health has accused Epic Systems of monopolistic business practices that hinder data-driven initiatives to improve patient care. Epic calls the complaint “baseless.” 

AB 3129 grants the Attorney General of California oversight of private equity transactions in healthcare. An attorney with Holland & Knight is concerned about the unintended consequences of the proposed law. 

In a statement announcing its lawsuit, the FTC said Caremark, Optum RX and Express Scripts benefit from manufacturer rebates and ignore lower-costing drugs as a way to artificially increase prices. 

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.